BIO logo

Bio-Rad Laboratories (BIO) Revenue

Annual revenue:

$2.57B-$104.70M(-3.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BIO annual revenue is $2.57 billion, with the most recent change of -$104.70 million (-3.92%) on December 31, 2024.
  • During the last 3 years, BIO annual revenue has fallen by -$356.05 million (-12.18%).
  • BIO annual revenue is now -12.18% below its all-time high of $2.92 billion, reached on December 31, 2021.

Performance

BIO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOincome statement metrics

Quarterly revenue:

$585.40M-$82.08M(-12.30%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BIO quarterly revenue is $585.40 million, with the most recent change of -$82.08 million (-12.30%) on March 31, 2025.
  • Over the past year, BIO quarterly revenue has dropped by -$25.40 million (-4.16%).
  • BIO quarterly revenue is now -25.88% below its all-time high of $789.84 million, reached on December 31, 2020.

Performance

BIO Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOincome statement metrics

TTM revenue:

$2.54B-$25.40M(-0.99%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BIO TTM revenue is $2.54 billion, with the most recent change of -$25.40 million (-0.99%) on March 31, 2025.
  • Over the past year, BIO TTM revenue has dropped by -$64.08 million (-2.46%).
  • BIO TTM revenue is now -14.72% below its all-time high of $2.98 billion, reached on September 30, 2021.

Performance

BIO TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOincome statement metrics

BIO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.9%-4.2%-2.5%
3 y3 years-12.2%-16.4%-12.3%
5 y5 years+11.0%+2.4%+9.1%

BIO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.2%at low-19.8%at low-12.3%at low
5 y5-year-12.2%+11.0%-25.9%+9.0%-14.7%+10.8%
alltimeall time-12.2%+2933.7%-25.9%+2812.4%-14.7%>+9999.0%

BIO Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$585.40M(-12.3%)
$2.54B(-1.0%)
Dec 2024
$2.57B(-3.9%)
$667.48M(+2.7%)
$2.57B(-0.5%)
Sep 2024
-
$649.73M(+1.8%)
$2.58B(+0.7%)
Jun 2024
-
$638.48M(+4.5%)
$2.56B(-1.6%)
Mar 2024
-
$610.80M(-10.3%)
$2.61B(-2.5%)
Dec 2023
$2.67B(-4.7%)
$681.12M(+7.8%)
$2.67B(-1.8%)
Sep 2023
-
$632.12M(-7.2%)
$2.72B(-1.8%)
Jun 2023
-
$681.11M(+0.6%)
$2.77B(-0.4%)
Mar 2023
-
$676.84M(-7.3%)
$2.78B(-0.8%)
Dec 2022
$2.80B(-4.1%)
$730.24M(+7.3%)
$2.80B(-0.1%)
Sep 2022
-
$680.80M(-1.5%)
$2.80B(-2.3%)
Jun 2022
-
$691.10M(-1.3%)
$2.87B(-0.9%)
Mar 2022
-
$700.06M(-4.5%)
$2.90B(-0.9%)
Dec 2021
$2.92B(+14.8%)
$732.77M(-1.9%)
$2.92B(-1.9%)
Sep 2021
-
$747.05M(+4.3%)
$2.98B(+3.5%)
Jun 2021
-
$715.93M(-1.5%)
$2.88B(+6.6%)
Mar 2021
-
$726.80M(-8.0%)
$2.70B(+6.1%)
Dec 2020
$2.55B(+10.1%)
$789.84M(+22.0%)
$2.55B(+6.9%)
Sep 2020
-
$647.26M(+20.6%)
$2.38B(+3.8%)
Jun 2020
-
$536.88M(-6.1%)
$2.29B(-1.5%)
Mar 2020
-
$571.64M(-8.5%)
$2.33B(+0.8%)
Dec 2019
$2.31B(+1.0%)
$624.43M(+11.4%)
$2.31B(+0.3%)
Sep 2019
-
$560.63M(-2.1%)
$2.30B(+0.7%)
Jun 2019
-
$572.62M(+3.4%)
$2.29B(-0.1%)
Mar 2019
-
$553.98M(-10.2%)
$2.29B(+0.1%)
Dec 2018
$2.29B(+6.0%)
$616.85M(+13.2%)
$2.29B(-0.2%)
Sep 2018
-
$545.14M(-5.3%)
$2.29B(+0.5%)
Jun 2018
-
$575.91M(+4.4%)
$2.28B(+3.2%)
Mar 2018
-
$551.52M(-11.2%)
$2.21B(+2.4%)
Dec 2017
$2.16B(+4.4%)
$621.29M(+16.3%)
$2.16B(+2.4%)
Sep 2017
-
$534.14M(+5.8%)
$2.11B(+1.2%)
Jun 2017
-
$504.67M(+0.9%)
$2.08B(-0.6%)
Mar 2017
-
$500.05M(-12.5%)
$2.10B(+1.4%)
Dec 2016
$2.07B(+2.4%)
$571.45M(+12.3%)
$2.07B(+0.0%)
Sep 2016
-
$508.75M(-1.6%)
$2.07B(+1.9%)
Jun 2016
-
$516.78M(+9.7%)
$2.03B(+0.5%)
Mar 2016
-
$471.20M(-17.4%)
$2.02B(-0.1%)
Dec 2015
$2.02B(-7.2%)
$570.56M(+21.4%)
$2.02B(-1.4%)
Sep 2015
-
$469.96M(-7.1%)
$2.05B(-2.9%)
Jun 2015
-
$506.10M(+7.0%)
$2.11B(-1.4%)
Mar 2015
-
$472.82M(-21.0%)
$2.14B(-1.7%)
Dec 2014
$2.18B(+2.0%)
$598.22M(+12.7%)
$2.18B(-0.2%)
Sep 2014
-
$530.64M(-1.2%)
$2.18B(+1.2%)
Jun 2014
-
$536.83M(+5.4%)
$2.15B(+0.5%)
Mar 2014
-
$509.34M(-15.5%)
$2.14B(+0.5%)
Dec 2013
$2.13B(+3.1%)
$602.63M(+19.3%)
$2.13B(+1.4%)
Sep 2013
-
$505.07M(-3.9%)
$2.10B(+0.3%)
Jun 2013
-
$525.32M(+5.1%)
$2.10B(+0.7%)
Mar 2013
-
$499.67M(-12.9%)
$2.08B(+0.6%)
Dec 2012
$2.07B(-0.2%)
$573.84M(+15.1%)
$2.07B(+1.2%)
Sep 2012
-
$498.70M(-2.3%)
$2.05B(-0.9%)
Jun 2012
-
$510.42M(+5.0%)
$2.06B(-0.5%)
Mar 2012
-
$486.28M(-11.6%)
$2.07B(+0.1%)
Dec 2011
$2.07B(+7.6%)
$550.24M(+6.5%)
$2.07B(+0.8%)
Sep 2011
-
$516.51M(-1.0%)
$2.06B(+2.2%)
Jun 2011
-
$521.66M(+7.5%)
$2.01B(+2.8%)
Mar 2011
-
$485.12M(-9.1%)
$1.96B(+1.6%)
Dec 2010
$1.93B(+8.0%)
$533.72M(+13.2%)
$1.93B(+2.0%)
Sep 2010
-
$471.50M(+0.8%)
$1.89B(+0.6%)
Jun 2010
-
$467.66M(+3.0%)
$1.88B(+2.2%)
Mar 2010
-
$454.23M(-8.2%)
$1.84B(+3.0%)
Dec 2009
$1.78B(+1.1%)
$495.07M(+7.4%)
$1.78B(+2.7%)
Sep 2009
-
$461.06M(+7.9%)
$1.74B(+1.1%)
Jun 2009
-
$427.18M(+6.5%)
$1.72B(-1.4%)
Mar 2009
-
$400.93M(-10.5%)
$1.74B(-1.2%)
Dec 2008
$1.76B(+20.8%)
$447.96M(+1.4%)
$1.76B(-0.7%)
Sep 2008
-
$441.84M(-2.3%)
$1.78B(+6.1%)
Jun 2008
-
$452.36M(+7.1%)
$1.67B(+7.3%)
Mar 2008
-
$422.20M(-8.2%)
$1.56B(+6.8%)
Dec 2007
$1.46B(+14.7%)
$459.69M(+35.3%)
$1.46B(+8.7%)
Sep 2007
-
$339.74M(+0.2%)
$1.34B(+2.7%)
Jun 2007
-
$339.11M(+5.1%)
$1.31B(+1.7%)
Mar 2007
-
$322.51M(-6.0%)
$1.29B(+1.1%)
Dec 2006
$1.27B(+7.9%)
$343.08M(+12.6%)
$1.27B(+2.9%)
Sep 2006
-
$304.76M(-4.1%)
$1.24B(+1.8%)
Jun 2006
-
$317.75M(+3.1%)
$1.22B(+2.2%)
Mar 2006
-
$308.34M(+0.3%)
$1.19B(+0.8%)
Dec 2005
$1.18B(+8.3%)
$307.29M(+8.5%)
$1.18B(-0.0%)
Sep 2005
-
$283.23M(-2.8%)
$1.18B(+2.1%)
Jun 2005
-
$291.30M(-2.6%)
$1.16B(+2.7%)
Mar 2005
-
$299.17M(-2.8%)
$1.13B(+3.3%)
Dec 2004
$1.09B
$307.87M(+18.9%)
$1.09B(+4.8%)
DateAnnualQuarterlyTTM
Sep 2004
-
$258.85M(-0.7%)
$1.04B(+1.7%)
Jun 2004
-
$260.55M(-0.8%)
$1.02B(+2.1%)
Mar 2004
-
$262.75M(+1.8%)
$1.00B(+1.7%)
Dec 2003
$979.63M(+13.3%)
$258.10M(+6.7%)
$985.20M(+4.5%)
Sep 2003
-
$241.81M(+1.0%)
$942.39M(+1.8%)
Jun 2003
-
$239.32M(-2.7%)
$925.46M(+2.7%)
Mar 2003
-
$245.97M(+14.3%)
$900.79M(+4.1%)
Dec 2002
$865.01M(+5.8%)
$215.29M(-4.3%)
$865.01M(-2.0%)
Sep 2002
-
$224.88M(+4.8%)
$883.10M(+4.6%)
Jun 2002
-
$214.66M(+2.1%)
$844.33M(+2.3%)
Mar 2002
-
$210.18M(-9.9%)
$825.02M(+0.9%)
Dec 2001
$817.51M(+12.6%)
$233.38M(+25.4%)
$817.51M(+7.3%)
Sep 2001
-
$186.10M(-4.7%)
$761.96M(+1.4%)
Jun 2001
-
$195.35M(-3.6%)
$751.62M(+1.1%)
Mar 2001
-
$202.67M(+14.0%)
$743.09M(+2.4%)
Dec 2000
$725.88M(+30.7%)
$177.83M(+1.2%)
$725.88M(-3.0%)
Sep 2000
-
$175.76M(-5.9%)
$748.35M(+9.1%)
Jun 2000
-
$186.83M(+0.7%)
$686.09M(+11.5%)
Mar 2000
-
$185.46M(-7.4%)
$615.06M(+10.8%)
Dec 1999
$555.40M(+24.0%)
$200.30M(+76.5%)
$555.33M(+15.7%)
Sep 1999
-
$113.50M(-2.0%)
$479.80M(+3.1%)
Jun 1999
-
$115.79M(-7.9%)
$465.30M(+1.7%)
Mar 1999
-
$125.74M(+0.8%)
$457.40M(+2.1%)
Dec 1998
$447.86M(+4.9%)
$124.76M(+26.0%)
$447.86M(+2.0%)
Sep 1998
-
$99.00M(-8.2%)
$438.90M(-0.1%)
Jun 1998
-
$107.90M(-7.1%)
$439.40M(+0.5%)
Mar 1998
-
$116.20M(+0.3%)
$437.30M(+2.4%)
Dec 1997
$426.90M(+1.9%)
$115.80M(+16.4%)
$427.00M(+0.4%)
Sep 1997
-
$99.50M(-6.0%)
$425.20M(+0.7%)
Jun 1997
-
$105.80M(-0.1%)
$422.30M(+1.4%)
Mar 1997
-
$105.90M(-7.1%)
$416.50M(-0.6%)
Dec 1996
$418.80M(+5.6%)
$114.00M(+18.0%)
$418.90M(+1.5%)
Sep 1996
-
$96.60M(-3.4%)
$412.80M(+0.9%)
Jun 1996
-
$100.00M(-7.7%)
$409.10M(+0.5%)
Mar 1996
-
$108.30M(+0.4%)
$407.00M(+2.6%)
Dec 1995
$396.60M(+11.6%)
$107.90M(+16.1%)
$396.60M(+2.9%)
Sep 1995
-
$92.90M(-5.1%)
$385.40M(+2.4%)
Jun 1995
-
$97.90M(0.0%)
$376.30M(+3.5%)
Mar 1995
-
$97.90M(+1.2%)
$363.50M(+2.3%)
Dec 1994
$355.30M(+8.1%)
$96.70M(+15.4%)
$355.30M(+2.7%)
Sep 1994
-
$83.80M(-1.5%)
$345.90M(+1.4%)
Jun 1994
-
$85.10M(-5.1%)
$341.00M(+1.0%)
Mar 1994
-
$89.70M(+2.7%)
$337.70M(+2.8%)
Dec 1993
$328.60M(-0.5%)
$87.30M(+10.6%)
$328.50M(-0.2%)
Sep 1993
-
$78.90M(-3.5%)
$329.30M(+0.1%)
Jun 1993
-
$81.80M(+1.6%)
$329.00M(+0.6%)
Mar 1993
-
$80.50M(-8.6%)
$327.20M(-0.9%)
Dec 1992
$330.30M(+6.3%)
$88.10M(+12.1%)
$330.30M(+1.8%)
Sep 1992
-
$78.60M(-1.8%)
$324.60M(+1.1%)
Jun 1992
-
$80.00M(-4.3%)
$321.10M(+1.1%)
Mar 1992
-
$83.60M(+1.5%)
$317.60M(+2.2%)
Dec 1991
$310.70M(+8.4%)
$82.40M(+9.7%)
$310.70M(+0.7%)
Sep 1991
-
$75.10M(-1.8%)
$308.60M(+1.8%)
Jun 1991
-
$76.50M(-0.3%)
$303.00M(+2.6%)
Mar 1991
-
$76.70M(-4.5%)
$295.30M(+3.0%)
Dec 1990
$286.70M(+21.3%)
$80.30M(+15.5%)
$286.70M(+5.7%)
Sep 1990
-
$69.50M(+1.0%)
$271.20M(+5.6%)
Jun 1990
-
$68.80M(+1.0%)
$256.80M(+3.5%)
Mar 1990
-
$68.10M(+5.1%)
$248.00M(+5.0%)
Dec 1989
$236.30M(+18.8%)
$64.80M(+17.6%)
$236.20M(+5.1%)
Sep 1989
-
$55.10M(-8.2%)
$224.70M(+4.1%)
Jun 1989
-
$60.00M(+6.6%)
$215.80M(+5.4%)
Mar 1989
-
$56.30M(+5.6%)
$204.80M(+2.9%)
Dec 1988
$198.90M(+24.7%)
$53.30M(+15.4%)
$199.00M(+4.8%)
Sep 1988
-
$46.20M(-5.7%)
$189.80M(+3.9%)
Jun 1988
-
$49.00M(-3.0%)
$182.60M(+5.9%)
Mar 1988
-
$50.50M(+14.5%)
$172.50M(+8.2%)
Dec 1987
$159.50M(+26.0%)
$44.10M(+13.1%)
$159.50M(+6.8%)
Sep 1987
-
$39.00M(+0.3%)
$149.40M(+5.6%)
Jun 1987
-
$38.90M(+3.7%)
$141.50M(+5.6%)
Mar 1987
-
$37.50M(+10.3%)
$134.00M(+5.9%)
Dec 1986
$126.60M(+23.8%)
$34.00M(+9.3%)
$126.50M(+5.7%)
Sep 1986
-
$31.10M(-1.0%)
$119.70M(+5.0%)
Jun 1986
-
$31.40M(+4.7%)
$114.00M(+6.1%)
Mar 1986
-
$30.00M(+10.3%)
$107.40M(+5.1%)
Dec 1985
$102.30M(+20.9%)
$27.20M(+7.1%)
$102.20M(+3.7%)
Sep 1985
-
$25.40M(+2.4%)
$98.60M(+5.7%)
Jun 1985
-
$24.80M(0.0%)
$93.30M(+4.9%)
Mar 1985
-
$24.80M(+5.1%)
$88.90M(+5.1%)
Dec 1984
$84.60M
$23.60M(+17.4%)
$84.60M(+38.7%)
Sep 1984
-
$20.10M(-1.5%)
$61.00M(+49.1%)
Jun 1984
-
$20.40M(-0.5%)
$40.90M(+99.5%)
Mar 1984
-
$20.50M
$20.50M

FAQ

  • What is Bio-Rad Laboratories annual revenue?
  • What is the all time high annual revenue for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories annual revenue year-on-year change?
  • What is Bio-Rad Laboratories quarterly revenue?
  • What is the all time high quarterly revenue for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories quarterly revenue year-on-year change?
  • What is Bio-Rad Laboratories TTM revenue?
  • What is the all time high TTM revenue for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories TTM revenue year-on-year change?

What is Bio-Rad Laboratories annual revenue?

The current annual revenue of BIO is $2.57B

What is the all time high annual revenue for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high annual revenue is $2.92B

What is Bio-Rad Laboratories annual revenue year-on-year change?

Over the past year, BIO annual revenue has changed by -$104.70M (-3.92%)

What is Bio-Rad Laboratories quarterly revenue?

The current quarterly revenue of BIO is $585.40M

What is the all time high quarterly revenue for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high quarterly revenue is $789.84M

What is Bio-Rad Laboratories quarterly revenue year-on-year change?

Over the past year, BIO quarterly revenue has changed by -$25.40M (-4.16%)

What is Bio-Rad Laboratories TTM revenue?

The current TTM revenue of BIO is $2.54B

What is the all time high TTM revenue for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high TTM revenue is $2.98B

What is Bio-Rad Laboratories TTM revenue year-on-year change?

Over the past year, BIO TTM revenue has changed by -$64.08M (-2.46%)
On this page